Nomogram for predicting the biochemical recurrence of prostate cancer after neoadjuvant androgen deprivation therapy

被引:0
|
作者
Qi Sun
Yuan-Zhong Yang
Ping Yang
Yong-Hong Li
Yun Cao
Dong Chen
Yijun Zhang
机构
[1] Collaborative Innovation Center for Cancer Medicine,State Key Laboratory of Oncology in South China
[2] Sun Yat-sen University Cancer Center,Department of Pathology
[3] Sun Yat-sen University Cancer Center,Department of Urology
来源
关键词
Prostate cancer; nADT; BCR; Predict; Nomogram;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2215 / 2224
页数:9
相关论文
共 50 条
  • [21] Is neoadjuvant androgen deprivation therapy beneficial in prostate cancer treated with definitive radiotherapy?
    Eom, Keun-Yong
    Ha, Sung W.
    Lee, Eunsik
    Kwak, Cheol
    Lee, Sang Eun
    RADIATION ONCOLOGY JOURNAL, 2014, 32 (04): : 247 - 255
  • [22] Effect of Neoadjuvant Intense Androgen Deprivation Therapy in Neuroendocrine Differentiation of Prostate Cancer
    Montaser, Laleh
    Calagua, Carla
    Schaefer, Rachel
    Lis, Rosina
    Zhang, Zhenwei
    Loda, Massimo
    Taplin, Mary-Ellen
    Balk, Steven P.
    Ye, Huihui
    MODERN PATHOLOGY, 2017, 30 : 244A - 244A
  • [23] USE OF NEOADJUVANT ANDROGEN DEPRIVATION THERAPY IN CLINICALLY LOCALIZED PROSTATE-CANCER
    FAIR, WR
    APRIKIAN, AG
    COHEN, D
    SOGANI, P
    REUTER, V
    CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1993, 16 (06): : 516 - 522
  • [24] Recovery of serum testosterone after neoadjuvant androgen deprivation therapy and radical radiotherapy in localized prostate cancer
    Murthy, V
    Norman, AR
    Shahidi, M
    Parker, CC
    Horwich, A
    Huddart, RA
    Bange, A
    Dearnaley, DP
    BJU INTERNATIONAL, 2006, 97 (03) : 476 - 479
  • [25] Factors associated with improved biochemical response to neoadjuvant androgen deprivation therapy before definitive radiation therapy in prostate cancer patients
    J Z Cerne
    S E McGuire
    S R Grant
    M F Munsell
    A K Lee
    R J Kudchadker
    S L Choi
    U Mahmood
    K E Hoffman
    T J Pugh
    S J Frank
    D A Kuban
    Prostate Cancer and Prostatic Diseases, 2013, 16 : 346 - 351
  • [26] Factors associated with improved biochemical response to neoadjuvant androgen deprivation therapy before definitive radiation therapy in prostate cancer patients
    Cerne, J. Z.
    McGuire, S. E.
    Grant, S. R.
    Munsell, M. F.
    Lee, A. K.
    Kudchadker, R. J.
    Choi, S. L.
    Mahmood, U.
    Hoffman, K. E.
    Pugh, T. J.
    Frank, S. J.
    Kuban, D. A.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2013, 16 (04) : 346 - 351
  • [27] Immunohistochemical changes in prostate cancer after androgen deprivation therapy
    Bostwick, DG
    MOLECULAR UROLOGY, 2000, 4 (03) : 101 - 106
  • [28] Androgen Deprivation Therapy for Prostate Cancer
    Pagliarulo, Vincenzo
    MOLECULAR & DIAGNOSTIC IMAGING IN PROSTATE CANCER: CLINICAL APPLICATIONS AND TREATMENT STRATEGIES, 2019, 1126 : 1 - 30
  • [29] Androgen deprivation therapy for prostate cancer
    Das, Manjulika
    LANCET ONCOLOGY, 2017, 18 (10): : E567 - E567
  • [30] Androgen deprivation therapy for prostate cancer
    Sharifi, N
    Gulley, JL
    Dahut, WL
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (02): : 238 - 244